IS5691A - Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone secretion (GHS) for the treatment of skeletal muscle weakness - Google Patents

Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone secretion (GHS) for the treatment of skeletal muscle weakness

Info

Publication number: IS5691A
Authority: IS; Iceland
Prior art keywords: treatment; ghs; serm; selective; growth hormone
Prior art date: 1998-06-16

Application number

IS5691A

Other languages

Icelandic (is)

Inventor

Zhu Ke Hua

Li Mei

Codetta Pan Lydia

Duane Thompson David

Original Assignee

Pfizer Products, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-16

Filing date

2000-10-27

Publication date

2000-10-27

2000-10-27 Application filed by Pfizer Products, Inc. filed Critical Pfizer Products, Inc.

2000-10-27 Publication of IS5691A publication Critical patent/IS5691A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Physical Education & Sports Medicine (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IS5691A 1998-06-16 2000-10-27 Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone secretion (GHS) for the treatment of skeletal muscle weakness IS5691A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8946998P	1998-06-16	1998-06-16
PCT/IB1999/001117 WO1999065486A1 (en)	1998-06-16	1999-06-16	Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (1)

Publication Number	Publication Date
IS5691A true IS5691A (en)	2000-10-27

Family

ID=22217825

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5691A IS5691A (en)	1998-06-16	2000-10-27	Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone secretion (GHS) for the treatment of skeletal muscle weakness

Country Status (30)

Country	Link
EP (1)	EP1087764A1 (en)
JP (1)	JP2002518326A (en)
KR (1)	KR20010052852A (en)
CN (1)	CN1301160A (en)
AP (1)	AP9901582A0 (en)
AR (1)	AR018869A1 (en)
AU (1)	AU4054799A (en)
BG (1)	BG105041A (en)
BR (1)	BR9911324A (en)
CA (1)	CA2335134A1 (en)
CO (1)	CO5070587A1 (en)
EA (1)	EA200001186A1 (en)
GT (1)	GT199900087A (en)
HN (1)	HN1999000097A (en)
HR (1)	HRP20000859A2 (en)
HU (1)	HUP0102505A3 (en)
ID (1)	ID27599A (en)
IL (1)	IL138630A0 (en)
IS (1)	IS5691A (en)
MA (1)	MA26652A1 (en)
NO (1)	NO20006312D0 (en)
OA (1)	OA11505A (en)
PA (1)	PA8475901A1 (en)
PE (1)	PE20000646A1 (en)
PL (1)	PL344981A1 (en)
SK (1)	SK18912000A3 (en)
TN (1)	TNSN99124A1 (en)
TR (1)	TR200003544T2 (en)
WO (1)	WO1999065486A1 (en)
ZA (1)	ZA993975B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2653300A (en) *	1999-02-08	2000-08-29	Mcgill University	Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha
EP1156120B1 (en)	2000-05-08	2006-11-22	Pfizer Products Inc.	Enzymatic resolution of selective estrogen receptor modulators
IL145106A0 (en) *	2000-08-30	2002-06-30	Pfizer Prod Inc	Intermittent administration of a geowth hormone secretagogue
JP2004507502A (en)	2000-08-30	2004-03-11	ファイザー・プロダクツ・インク	Sustained release formulation for growth hormone secretagogue
US7476653B2 (en)	2003-06-18	2009-01-13	Tranzyme Pharma, Inc.	Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) *	2004-08-31	2006-03-09	Pfizer Products Inc.	Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (en)	2006-02-28	2010-07-20	Ct Ingenieria Genetica Biotech	COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
WO2008130464A1 (en)	2007-02-09	2008-10-30	Tranzyme Pharma, Inc.	Macrocyclic ghrelin receptor modulators and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA51676C2 (en) *	1995-11-02	2002-12-16	Пфайзер Інк.	(-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-I-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate, a method of its preparation, method of THE treatment OF diseases medicated by agonists of estrogen and a pharmaceutical composition
TW432073B (en) *	1995-12-28	2001-05-01	Pfizer	Pyrazolopyridine compounds
HN1996000101A (en) *	1996-02-28	1997-06-26	Inc Pfizer	COMBINED THERAPY FOR OSTEOPOROSIS

1999
- 1999-06-15 PA PA19998475901A patent/PA8475901A1/en unknown
- 1999-06-15 PE PE1999000528A patent/PE20000646A1/en not_active Application Discontinuation
- 1999-06-15 HN HN1999000097A patent/HN1999000097A/en unknown
- 1999-06-15 AR ARP990102848A patent/AR018869A1/en not_active Application Discontinuation
- 1999-06-15 ZA ZA9903975A patent/ZA993975B/en unknown
- 1999-06-15 AP APAP/P/1999/001582A patent/AP9901582A0/en unknown
- 1999-06-16 HU HU0102505A patent/HUP0102505A3/en unknown
- 1999-06-16 CO CO99037622A patent/CO5070587A1/en unknown
- 1999-06-16 AU AU40547/99A patent/AU4054799A/en not_active Abandoned
- 1999-06-16 TN TNTNSN99124A patent/TNSN99124A1/en unknown
- 1999-06-16 MA MA25628A patent/MA26652A1/en unknown
- 1999-06-16 WO PCT/IB1999/001117 patent/WO1999065486A1/en not_active Application Discontinuation
- 1999-06-16 BR BR9911324-4A patent/BR9911324A/en not_active Application Discontinuation
- 1999-06-16 JP JP2000554366A patent/JP2002518326A/en active Pending
- 1999-06-16 PL PL99344981A patent/PL344981A1/en not_active Application Discontinuation
- 1999-06-16 CA CA002335134A patent/CA2335134A1/en not_active Abandoned
- 1999-06-16 CN CN99806237A patent/CN1301160A/en active Pending
- 1999-06-16 TR TR2000/03544T patent/TR200003544T2/en unknown
- 1999-06-16 EA EA200001186A patent/EA200001186A1/en unknown
- 1999-06-16 IL IL13863099A patent/IL138630A0/en unknown
- 1999-06-16 KR KR1020007014186A patent/KR20010052852A/en not_active Ceased
- 1999-06-16 GT GT199900087A patent/GT199900087A/en unknown
- 1999-06-16 EP EP99923802A patent/EP1087764A1/en not_active Withdrawn
- 1999-06-16 SK SK1891-2000A patent/SK18912000A3/en unknown
- 1999-06-16 HR HR20000859A patent/HRP20000859A2/en not_active Application Discontinuation
- 1999-06-16 ID IDW20002627A patent/ID27599A/en unknown
2000
- 2000-10-20 OA OA1200000290A patent/OA11505A/en unknown
- 2000-10-27 IS IS5691A patent/IS5691A/en unknown
- 2000-12-11 BG BG105041A patent/BG105041A/en unknown
- 2000-12-12 NO NO20006312A patent/NO20006312D0/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO1999065486A1 (en)	1999-12-23
KR20010052852A (en)	2001-06-25
HUP0102505A2 (en)	2001-11-28
IL138630A0 (en)	2001-10-31
GT199900087A (en)	2000-12-07
NO20006312L (en)	2000-12-12
AR018869A1 (en)	2001-12-12
SK18912000A3 (en)	2001-10-08
BR9911324A (en)	2001-04-03
TNSN99124A1 (en)	2005-11-10
JP2002518326A (en)	2002-06-25
CN1301160A (en)	2001-06-27
CA2335134A1 (en)	1999-12-23
PE20000646A1 (en)	2000-08-05
ID27599A (en)	2001-04-12
MA26652A1 (en)	2004-12-20
AP9901582A0 (en)	1999-06-30
HRP20000859A2 (en)	2001-04-30
HN1999000097A (en)	1999-11-03
PL344981A1 (en)	2001-11-19
EA200001186A1 (en)	2001-06-25
NO20006312D0 (en)	2000-12-12
CO5070587A1 (en)	2001-08-28
BG105041A (en)	2001-08-31
AU4054799A (en)	2000-01-05
HUP0102505A3 (en)	2002-12-28
TR200003544T2 (en)	2001-04-20
EP1087764A1 (en)	2001-04-04
ZA993975B (en)	2000-12-15
PA8475901A1 (en)	2000-05-24
OA11505A (en)	2004-05-07

Publication	Publication Date	Title
IS2595B (en)	2010-03-15	Protein blend and process for isolating protein mixture from muscle tissue
GB2361878B (en)	2003-02-19	Bone cement mixer and method
DK0946190T3 (en)	2003-12-08	Methods and Compositions for Stimulating Neurite Growth
NO981426D0 (en)	1998-03-30	Method and apparatus for primary-well cementing
AU6459000A (en)	2001-03-05	Method and apparatus for delivering cement to bones and/or positioning components
DE69837264D1 (en)	2007-04-19	DIPEPTIDE DERIVATIVES FOR PROMOTING THE SECRETION OF GROWTH HORMONE
DK1181397T3 (en)	2003-11-24	Rhodium electrocatalyst and process for its preparation
HUP0003051A3 (en)	2004-04-28	Method and apparatus for producing cement clinker
NO20010468D0 (en)	2001-01-26	Use of biogenic estrogen sulfamates for hormone replacement therapy
DK0808577T3 (en)	2003-03-10	Method and apparatus for making aerated frozen products
DK0831098T3 (en)	2002-05-21	Intermediates and process for the preparation of olanzapine
IS5691A (en)	2000-10-27	Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone secretion (GHS) for the treatment of skeletal muscle weakness
DK3497A (en)	1997-07-11	Sustained release formulation of an animal growth hormone and process for its preparation
DK0977736T3 (en)	2004-01-19	Process for the preparation of pure flupirtine maleate and its modification A
IS5719A (en)	2000-11-21	Treatment combinations consisting of selective estrogen receptor modulator and parathyroid hormone
DK0911303T4 (en)	2008-01-02	Method and system for controlling mixing of raw materials for cement
DK0923599T3 (en)	2002-04-22	Process for Preparation of 17-Esters of 9alpha, 21-Dihalo-Pregnan-11beta, 17alpha-Diol-20-One
IS5727A (en)	2000-11-24	Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone (GHS) to treat skeletal muscle weakness
GB9913560D0 (en)	1999-08-11	Mixing apparatus and method of mixing
DE69836870D1 (en)	2007-02-22	Interface adaptation circuit and method for its adjustment
DK1031575T3 (en)	2005-01-03	Process for Preparation of Growth Hormone Secretion Inducers
AP9700913A0 (en)	1997-01-31	Establishment of tonic ovarian estrogen secretion for extended therapeutic regiments
DK0953291T3 (en)	2002-10-28	Method and machine for refining confectionery material
PL336422A1 (en)	2000-06-19	Method of and apparatus for preparing asphalt mixes
DK1093361T3 (en)	2003-08-25	Steroid-containing patch, method for its preparation and use